{"transactions":[{"id":808183,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:53:44.000Z","date":"2026-04-14","kind":"sale","planned":true,"acquired":false,"shares":6257,"price":69.2399,"value":433234.0543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $69.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":64333,"source":{"system":"sec-edgar","filing":"0001193125-26-157187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526157187/ownership.xml","form_type":"4"}},{"id":808182,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:53:44.000Z","date":"2026-04-13","kind":"sale","planned":true,"acquired":false,"shares":400,"price":69,"value":27600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025."}],"balance_after":70590,"source":{"system":"sec-edgar","filing":"0001193125-26-157187","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526157187/ownership.xml","form_type":"4"}},{"id":877400,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:37.000Z","date":"2026-02-25","kind":"sale","planned":true,"acquired":false,"shares":353,"price":69.0569,"value":24377.0857,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.00 to $69.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":70990,"source":{"system":"sec-edgar","filing":"0001193125-26-083027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526083027/ownership.xml","form_type":"4"}},{"id":893524,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-19T22:42:56.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3684,"price":65.8889,"value":242734.7076,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.51 to $66.38, inclusive."}],"balance_after":71343,"source":{"system":"sec-edgar","filing":"0001193125-26-059760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526059760/ownership.xml","form_type":"4"}},{"id":893523,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-19T22:42:56.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3397,"price":65.0097,"value":220837.9509,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.47 to $65.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (4) to this Form 4."}],"balance_after":75027,"source":{"system":"sec-edgar","filing":"0001193125-26-059760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526059760/ownership.xml","form_type":"4"}},{"id":893522,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-19T22:42:56.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":4075,"price":62.86,"value":256154.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I. This sale is a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":78424,"source":{"system":"sec-edgar","filing":"0001193125-26-059760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526059760/ownership.xml","form_type":"4"}},{"id":910067,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-12T00:26:56.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":25500,"derivative":{"exercise_price":74.75,"expiration_date":"2036-02-09","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001193125-26-047163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526047163/ownership.xml","form_type":"4"}},{"id":910066,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-12T00:26:56.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":82499,"source":{"system":"sec-edgar","filing":"0001193125-26-047163","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000119312526047163/ownership.xml","form_type":"4"}},{"id":946309,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:27:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000074/form4.xml","form_type":"4"}},{"id":946308,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:27:18.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":8164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":8164,"derivative":{"underlying":"Common Stock","underlying_shares":8164},"source":{"system":"sec-edgar","filing":"0000905148-26-000074","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000074/form4.xml","form_type":"4"}},{"id":1084752,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-18T20:51:40.000Z","date":"2025-07-17","kind":"sale","planned":true,"acquired":false,"shares":2031,"price":59,"value":119829.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025."}],"balance_after":63499,"source":{"system":"sec-edgar","filing":"0000950170-25-096967","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025096967/ownership.xml","form_type":"4"}},{"id":1088076,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-15T01:36:40.000Z","date":"2025-07-10","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":57.5,"value":115000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported by the Reporting Person was effected pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025."}],"balance_after":65530,"source":{"system":"sec-edgar","filing":"0000950170-25-095684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025095684/ownership.xml","form_type":"4"}},{"id":1106411,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-18T21:18:29.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":52.2594,"value":104518.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.79 to $52.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":67530,"source":{"system":"sec-edgar","filing":"0000950170-25-087963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025087963/ownership.xml","form_type":"4"}},{"id":1136966,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T20:14:26.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001892","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001892/form4.xml","form_type":"4"}},{"id":1136965,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:14:26.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":92429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":92429,"derivative":{"underlying":"Common Stock","underlying_shares":92429},"source":{"system":"sec-edgar","filing":"0000905148-25-001892","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001892/form4.xml","form_type":"4"}},{"id":1183208,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-04-02T20:26:21.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":false,"shares":26368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These fully vested RSUs settled on April 1, 2025, and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These fully vested RSUs settled on April 1, 2025, and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26368},"source":{"system":"sec-edgar","filing":"0000905148-25-001049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001049/form4.xml","form_type":"4"}},{"id":1183207,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-02T20:26:21.000Z","date":"2025-04-01","kind":"exercise","planned":false,"acquired":true,"shares":26368,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":108140,"source":{"system":"sec-edgar","filing":"0000905148-25-001049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001049/form4.xml","form_type":"4"}},{"id":1255983,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-21T00:29:34.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":3136,"price":54.58,"value":171162.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units granted on February 7, 2024 and previously reported in Table I. This sale is a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":69530,"source":{"system":"sec-edgar","filing":"0000950170-25-024472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025024472/ownership.xml","form_type":"4"}},{"id":1271843,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-12T23:38:29.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 equal monthly installments commencing on March 10, 2025, subject to the Reporting Person's continuted service on each such vesting date."}],"balance_after":36000,"derivative":{"exercise_price":54.71,"expiration_date":"2035-02-09","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000950170-25-019092","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025019092/ownership.xml","form_type":"4"}},{"id":1271842,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T23:38:29.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest annually in four 25% installments commencing on February 15, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":72666,"source":{"system":"sec-edgar","filing":"0000950170-25-019092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017025019092/ownership.xml","form_type":"4"}},{"id":1503550,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T23:13:18.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001607/form4.xml","form_type":"4"}},{"id":1503549,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T23:13:18.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":60766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":60766,"derivative":{"underlying":"Common Stock","underlying_shares":60766},"source":{"system":"sec-edgar","filing":"0000905148-24-001607","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001607/form4.xml","form_type":"4"}},{"id":1641151,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T01:37:53.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option shall vest and become exercisable on February 7, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":65.25,"expiration_date":"2034-02-06","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-24-016133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024016133/ownership.xml","form_type":"4"}},{"id":1641150,"issuer":{"id":2273,"kind":"organization","name":"Disc Medicine, Inc.","symbol":"IRON"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-16T01:37:53.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36666,"source":{"system":"sec-edgar","filing":"0000950170-24-016133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816736/000095017024016133/ownership.xml","form_type":"4"}},{"id":1692037,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:14:49.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":145811,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000039/form4.xml","form_type":"4"}},{"id":1813771,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:28:03.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":61728,"price":1.62,"value":99999.36,"ownership":{"direct":true},"balance_after":81772,"source":{"system":"sec-edgar","filing":"0000905148-23-000619","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000619/form4.xml","form_type":"4"}},{"id":1877970,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T22:22:19.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":40422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":40422,"derivative":{"underlying":"Common Stock","underlying_shares":40422},"source":{"system":"sec-edgar","filing":"0001140361-23-026721","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123026721/form4.xml","form_type":"4"}},{"id":1886434,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T00:32:47.000Z","date":"2023-05-16","kind":"sale","planned":false,"acquired":false,"shares":11351,"price":18.05,"value":204885.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.05 to $18.23. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":128748,"source":{"system":"sec-edgar","filing":"0001104659-23-062374","document":"tm2316199-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465923062374/tm2316199-5_4seq1.xml","form_type":"4"}},{"id":1926689,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T00:01:58.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2024, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":67500,"derivative":{"exercise_price":17.66,"expiration_date":"2033-04-01","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001104659-23-041725","document":"tm2311410-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465923041725/tm2311410-6_4seq1.xml","form_type":"4"}},{"id":1926688,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-05T00:01:58.000Z","date":"2023-04-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2024 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2027, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":140099,"source":{"system":"sec-edgar","filing":"0001104659-23-041725","document":"tm2311410-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465923041725/tm2311410-6_4seq1.xml","form_type":"4"}},{"id":2062437,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-05T21:31:16.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":7317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":153150,"derivative":{"underlying":"Common Stock","underlying_shares":7317},"source":{"system":"sec-edgar","filing":"0001140361-23-000667","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000667/form4.xml","form_type":"4"}},{"id":2067060,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-04T23:20:21.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000517/form4.xml","form_type":"4"}},{"id":2255122,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-26T20:15:37.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122020780/form4.xml","form_type":"4"}},{"id":2265142,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-18T23:03:03.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":3436,"price":14.59,"value":50131.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units (\"RSU\"). The transaction reported herein was made in accordance with the irrevocable \"sell to cover\" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.57 to $14.59. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":95099,"source":{"system":"sec-edgar","filing":"0001104659-22-062609","document":"tm2215879-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465922062609/tm2215879-6_4seq1.xml","form_type":"4"}},{"id":2303409,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-04-05T20:17:41.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":78750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2023, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":78750,"derivative":{"exercise_price":18.26,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":78750},"source":{"system":"sec-edgar","filing":"0001104659-22-042770","document":"tm2211665-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465922042770/tm2211665-3_4seq1.xml","form_type":"4"}},{"id":2303408,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:17:41.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2023 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2026, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":98535,"source":{"system":"sec-edgar","filing":"0001104659-22-042770","document":"tm2211665-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465922042770/tm2211665-3_4seq1.xml","form_type":"4"}},{"id":2307981,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-04-04T20:16:09.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":20044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vested in full on March 31, 2022 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vested in full on March 31, 2022 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20044},"source":{"system":"sec-edgar","filing":"0001140361-22-012922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122012922/form4.xml","form_type":"4"}},{"id":2307980,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T20:16:09.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":20044,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":20044,"source":{"system":"sec-edgar","filing":"0001140361-22-012922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122012922/form4.xml","form_type":"4"}},{"id":2647490,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-07-01T22:25:19.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":20044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will vest in full on March 31, 2022 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will vest in full on March 31, 2022 and have no expiration date."}],"balance_after":20044,"derivative":{"underlying":"Common Stock","underlying_shares":20044},"source":{"system":"sec-edgar","filing":"0000905148-21-000540","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514821000540/form4.xml","form_type":"4"}},{"id":2756659,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-04-06T00:19:18.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":69050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":69050,"derivative":{"exercise_price":31.58,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":69050},"source":{"system":"sec-edgar","filing":"0001104659-21-046731","document":"tm2112099-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921046731/tm2112099-12_4seq1.xml","form_type":"4"}},{"id":2756658,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-06T00:19:18.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":46035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units (\"RSUs\") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer."}],"balance_after":46035,"source":{"system":"sec-edgar","filing":"0001104659-21-046731","document":"tm2112099-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921046731/tm2112099-12_4seq1.xml","form_type":"4"}},{"id":2905530,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":14900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying this stock option vested on December 9, 2020, the remainder of the shares underlying this stock option will continue to vest in approximately equal monthly installments thereafter until December 9, 2023."}],"balance_after":140000,"derivative":{"exercise_price":14.08,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":14900},"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905529,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares underlying this stock option vested on December 9, 2020, the remainder of the shares underlying this stock option will continue to vest in approximately equal monthly installments thereafter until December 9, 2023."}],"balance_after":154900,"derivative":{"exercise_price":14.08,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905528,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":600,"price":44,"value":26400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person continues to hold options to acquire 196,350 shares of the Issuer's common stock, 8,750 of which are exercisable as of the date hereof."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905527,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":14300,"price":44.55,"value":637065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.01 to $45.00. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905526,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":14900,"price":14.08,"value":209792.0,"ownership":{"direct":true},"balance_after":14900,"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905525,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-13","kind":"sale","acquired":false,"shares":100,"price":44.19,"value":4419.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2905524,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-16T02:01:32.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":100,"price":14.08,"value":1408.0,"ownership":{"direct":true},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001104659-21-004879","document":"tm213368-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465921004879/tm213368-1_4seq1.xml","form_type":"4"}},{"id":2941826,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-17T02:00:19.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares underlying this stock option vested on December 9, 2020, the remainder of the shares underlying this stock option will continue to vest in equal monthly installments thereafter until December 9, 2023."}],"balance_after":155000,"derivative":{"exercise_price":14.08,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-136479","document":"tm2038707d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920136479/tm2038707d1_4.xml","form_type":"4"}},{"id":2941825,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T02:00:19.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":389,"price":42.09,"value":16373.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.01 to $42.15. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The reporting person continues to hold options to acquire 211,350 shares of the Issuer's common stock, 20,000 of which are exercisable as of the date hereof."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-136479","document":"tm2038707d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920136479/tm2038707d1_4.xml","form_type":"4"}},{"id":2941824,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T02:00:19.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":6755,"price":42.86,"value":289519.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.24 to $43.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":389,"source":{"system":"sec-edgar","filing":"0001104659-20-136479","document":"tm2038707d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920136479/tm2038707d1_4.xml","form_type":"4"}},{"id":2941823,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T02:00:19.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":17856,"price":43.7,"value":780307.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.22 to $44.21. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7144,"source":{"system":"sec-edgar","filing":"0001104659-20-136479","document":"tm2038707d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920136479/tm2038707d1_4.xml","form_type":"4"}},{"id":2941822,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-17T02:00:19.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":25000,"price":14.08,"value":352000.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-20-136479","document":"tm2038707d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920136479/tm2038707d1_4.xml","form_type":"4"}},{"id":3185711,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-04-02T20:34:17.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":56350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on April 1, 2021, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":56350,"derivative":{"exercise_price":9.78,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":56350},"source":{"system":"sec-edgar","filing":"0001104659-20-042509","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465920042509/a4.xml","form_type":"4"}},{"id":3344804,"issuer":{"id":4707,"kind":"organization","name":"Replimune Group, Inc."},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-11T23:02:21.000Z","date":"2019-12-09","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this stock option vest on December 9, 2020, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter."}],"balance_after":180000,"derivative":{"exercise_price":14.08,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-19-071921","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1653053/000110465919071921/a4.xml","form_type":"4"}},{"id":3731967,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-13T16:16:26.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/12th of the total number of shares granted on 3/11/19 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 12/11/21."}],"balance_after":45000,"derivative":{"exercise_price":4.15,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-062435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919118062435/doc4.xml","form_type":"4"}},{"id":4051603,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T16:08:24.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/12th of the total number of shares granted on 5/15/18 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 2/15/21."}],"balance_after":45000,"derivative":{"exercise_price":10.74,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-010811","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919118010811/doc4.xml","form_type":"4"}},{"id":4223415,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-08-28T16:54:03.000Z","date":"2017-08-24","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/6th of the total number of shares granted on 2/21/18 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 8/21/20."}],"balance_after":450000,"derivative":{"exercise_price":1.32,"expiration_date":"2027-08-23","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-17-050426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919117050426/doc4.xml","form_type":"4"}},{"id":4467831,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":52404,"kind":"person","name":"Franchi Jean M.","position":1,"cik":"0001653053","reported_name":"Franchi Jean M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-03T16:39:06.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option vests in forty-eight (48) equal monthly installments beginning on January 18, 2017."}],"balance_after":60000,"derivative":{"exercise_price":1.9,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-17-007647","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1592288/000120919117007647/doc4.xml","form_type":"4"}}]}